RMR Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-418
Closed -$319K 78
2025
Q3
$319K Hold
418
0.22% 65
2025
Q2
$326K Hold
418
0.23% 64
2025
Q1
$345K Hold
418
0.25% 61
2024
Q4
$323K Hold
418
0.24% 62
2024
Q3
$370K Hold
418
0.3% 56
2024
Q2
$378K Hold
418
0.35% 51
2024
Q1
$325K Hold
418
0.3% 54
2023
Q4
$244K Buy
+418
New +$244K 0.28% 55

Other funds holding LLY

RMR Capital Management's LLY Position: Q4 2025 in Review

RMR Capital Management sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 418 shares — an estimated $319K sold.

RMR Capital Management first reported a position in LLY in Q4 2023 and held it in 8 quarters. The position peaked at $378K in Q2 2024. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • RMR Capital Management reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
  • RMR Capital Management sold 418 Eli Lilly shares in Q4 2025, an estimated $319K.
  • RMR Capital Management first reported a position in Eli Lilly in Q4 2023 and held it in 8 quarters.
  • RMR Capital Management's Eli Lilly position peaked at $378K in Q2 2024.
  • 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on RMR Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.